News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,182 Results
Type
Article (31706)
Company Profile (58)
Press Release (361418)
Section
Business (112655)
Career Advice (1320)
Deals (24026)
Drug Delivery (89)
Drug Development (59623)
Employer Resources (102)
FDA (9904)
Job Trends (9065)
News (211239)
Policy (25471)
Tag
Academia (1827)
Alliances (42190)
Alzheimer's disease (1047)
Approvals (9875)
Artificial intelligence (119)
Bankruptcy (230)
Best Places to Work (7680)
Breast cancer (153)
Cancer (1186)
Cardiovascular disease (86)
Career advice (1109)
CAR-T (80)
Cell therapy (229)
Clinical research (47609)
Collaboration (508)
Compensation (257)
COVID-19 (2452)
Data (1099)
Diabetes (158)
Diagnostics (3482)
Drug pricing (89)
Earnings (39548)
Employer resources (94)
Events (45076)
Executive appointments (229)
FDA (10488)
Funding (354)
Gene therapy (174)
GLP-1 (624)
Government (4039)
Healthcare (11386)
Infectious disease (2548)
Interviews (229)
IPO (10391)
Job creations (1745)
Job search strategy (955)
Layoffs (257)
Legal (7023)
Lung cancer (177)
Lymphoma (80)
Manufacturing (167)
Medical device (5879)
Medtech (5880)
Mergers & acquisitions (13878)
Metabolic disorders (453)
Neuroscience (1339)
NextGen: Class of 2025 (3655)
Non-profit (2767)
Northern California (1213)
Obesity (273)
Opinion (181)
Parkinson's disease (88)
Patents (99)
People (24588)
Phase I (14388)
Phase II (20683)
Phase III (16755)
Pipeline (491)
Policy (85)
Postmarket research (1846)
Preclinical (5945)
Radiopharmaceuticals (200)
Rare diseases (218)
Real estate (2574)
Regulatory (15830)
Research institute (1588)
Resumes & cover letters (195)
Southern California (993)
Startups (1881)
United States (10027)
Vaccines (622)
Weight loss (216)
Date
Today (23)
Last 7 days (364)
Last 30 days (1658)
Last 365 days (22074)
2025 (1711)
2024 (22352)
2023 (25258)
2022 (33379)
2021 (35888)
2020 (34074)
2019 (27911)
2018 (21235)
2017 (20187)
2016 (18692)
2015 (21494)
2014 (15948)
2013 (12876)
2012 (13623)
2011 (14401)
2010 (13078)
Location
Africa (566)
Asia (25681)
Australia (4628)
California (2640)
Canada (973)
China (269)
Colorado (116)
Connecticut (117)
Europe (61506)
Florida (380)
Georgia (95)
Illinois (235)
Indiana (153)
Japan (83)
Maryland (526)
Massachusetts (1926)
Michigan (89)
Minnesota (109)
New Jersey (826)
New York (811)
North Carolina (405)
Northern California (1213)
Ohio (89)
Pennsylvania (595)
South America (794)
Southern California (993)
Texas (328)
Washington State (241)
393,182 Results for "bioversys ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
BioVersys AG announced the expansion of its strategic collaboration with the global biopharma company GSK plc to accelerate the clinical development of alpibectir for the treatment of tuberculosis.
May 7, 2024
·
4 min read
BioVersys Awarded Non-Dilutive Funding From CF AMR Syndicate Collaborative Discovery Programme
BioVersys AG announced that it has received a non-dilutive award from the CF AMR Syndicate of up to £ 500,000, via a LifeArc funded Collaborative Discovery Programme award, to support the development of novel small molecules targeting difficult to treat non-tubercular mycobacteria lung disease in people with cystic fibrosis.
June 4, 2024
·
10 min read
Press Releases
BioVersys Joins EU-Funded RespiriNTM Programme to Accelerate Development of Its Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases
October 22, 2024
·
8 min read
Press Releases
Bioversys Announces Strategic Investment From GIBF2 and Launch of BV100 Clinical Program in China
September 11, 2024
·
4 min read
Press Releases
Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update
October 16, 2024
·
9 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Business
OpGen Subsidiary Curetis and BioVersys Sign Collaboration Agreement for Clinical Trial Support
OpGen, Inc. and BioVersys AG today announced the signing of a collaboration agreement for the deployment and use of the Unyvero platform in BioVersys’ upcoming Phase II clinical trial of novel drug candidate BV100.
October 25, 2022
·
6 min read
Press Releases
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
January 8, 2025
·
7 min read
Press Releases
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
January 31, 2025
·
5 min read
1 of 39,319
Next
